OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer
Fabrice Barlési, Byoung Chul Cho, Sarah B. Goldberg, et al.
Future Oncology (2024) Vol. 20, Iss. 29, pp. 2137-2147
Open Access | Times Cited: 4
Fabrice Barlési, Byoung Chul Cho, Sarah B. Goldberg, et al.
Future Oncology (2024) Vol. 20, Iss. 29, pp. 2137-2147
Open Access | Times Cited: 4
Showing 4 citing articles:
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Targeted and cytotoxic inhibitors used in the treatment of lung cancers
Robert Roskoski
Pharmacological Research (2024), pp. 107465-107465
Open Access | Times Cited: 4
Robert Roskoski
Pharmacological Research (2024), pp. 107465-107465
Open Access | Times Cited: 4
Recent advances in therapeutic strategies for non-small cell lung cancer
Po‐Lan Su, Naoki Furuya, Atif Asrar, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Po‐Lan Su, Naoki Furuya, Atif Asrar, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Operables nichtkleinzelliges Lungenkarzinom: Neoadjuvante versus adjuvante Therapie
Frank Griesinger
Trillium Krebsmedizin (2025) Vol. 34, Iss. 2, pp. 79-85
Closed Access
Frank Griesinger
Trillium Krebsmedizin (2025) Vol. 34, Iss. 2, pp. 79-85
Closed Access
